Diabetes 2 - type készítmények kezelésére

Ezen rendszerekben is helye lehet helye van a metforminnak. Arch Intern Med Halmos T: A 2. Orv Hetil A contribution to the implementation of the St. Vincent Declaration. Verlag Kirhcheim, Mainz Diabetes Care Bailey, CJ: New insulin secretagogues.

Diab Rev Internat 7: Taking a more aggressive approach of therapy. Postgrad Med N Engl J Med Praxis 6:vércukormérő tesztcsík Diabetol Hung 2 N o 4 : University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: V.
Evaluation of phenformin therapy. Diabetes 24 Suppl.

Magy Belorv Arch 19 Suppl. Sirtori, CR, Pasik, C: Re-evaluation of a biguanide, metformin: mechanism of action and tolerability.

Pharmacol Res Lancet Grant, PJ: The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects.
Diab Stoffwechs 7: Eur J Clin Pharmacol Amer J Med Schwarzbeck, A: Non-steroidal anti-inflammatory drugs and metformin.
Diabetes Mellitus Type 1 for USMLE Step1 and USMLE Step 2
Diabetol Hung. Birkeland, KI: Improving glycaemic control with current therapies.

Diabetic Med 15 Suppl 4 : SS19, Diabetol Hung 6: Medicina, Budapest, pp. Diabetes Care 3844, Diabetes Care , Diabetes Care 22 Suppl 1 : S27S31,
